Bilal Ansari

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Comparison of younger and older breast cancer survivors and age‐matched controls on specific and overall quality of life domains

Victoria L. Champion, Lynne I. Wagner, Patrick O. Monahan et al. · Cancer · 2014 · 263 citations · Full text

Left Atrial Phasic Function by Cardiac Magnetic Resonance Feature Tracking Is a Strong Predictor of Incident Cardiovascular Events

Julio A. Chirinos, Mayank Sardana, Bilal Ansari et al. · Circulation Cardiovascular Imaging · 2018 · 121 citations · Full text

L-Carnitine Supplementation for the Management of Fatigue in Patients With Cancer: An Eastern Cooperative Oncology Group Phase III, Randomized, Double-Blind, Placebo-Controlled Trial

Ricardo A. Cruciani, Jenny J. Zhang, Judith Manola et al. · Journal of Clinical Oncology · 2012 · 97 citations · Full text

Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness

Houry Puzantian, Scott Akers, Garrett Oldland et al. · American Journal of Hypertension · 2018 · 75 citations · Full text